A Chiamydia trachomais D* serovariant strain was found to be mixed with an F serovar strain in a clinical specimen. By using a monoclonal antibody which neutralizes serovar F infectivity in hamster kidney cells, the D* variant strain was enriched until it could be cloned by limiting dilution. This newly described neutralization enrichment procedure can be used to purify a C. trachomatis serovar The original specimen consisted of cervical secretions collected from a patient with pelvic inflammatory disease. We cultured the specimen for C. trachomatis using our previously reported microtiter plate culture method (3).
increase the inoculum for another cycle of neutralization, and the F and D* titers were determined. After this first neutralization, the proportion of the inoculum containing the F strain fell to approximately 96% and the proportion of the inoculum containing the D* strain increased to 4% (Table 2) .
From these results, it was clear that MAb FC-2 had F serovar-neutralizing properties. To further purify the D* variant, two more cycles of MAb FC-2 neutralizations were carried out until the D* variant made up 93% of the population (Table 2) . At this point, the mixed culture was diluted and aliquots were cultured. The dilution with the lowest number of IFUs was passed to boost the total number of organisms, and the resulting chlamydiae were serotyped. As can be seen in we had purified the D* serovariant away from the F serovar.
The method described here provides a new tool for experimental studies with C. trachomatis. Since this organism cannot be grown in artificial growth medium, a mixture of two strains cannot be separated by subculturing different colonies. It is sometimes possible to purify one C. trachomatis serovar from a second serovar in the same culture by diluting the sample and culturing the dilution, which theoretically should have 1 IFU in the aliquot. If the two serovars are present in equal numbers in the original culture, either one or the other serovar will grow from that single IFU. If one of the serovars is present in much higher numbers than the other, it will be more likely to grow from the single IFU and the other strain will be lost. Since we were interested in determining the sequence of the D* variant's MOMP gene, we wished to purify it from the F serovar, which was the predominant organism in this specimen. We reasoned that we could accomplish this by neutralizing the F serovar infectivity of the HaK cells used to propagate the mixture of organisms. The methods described here, neutralization of one strain and limiting dilution, resulted in separation of one strain from another, even when the one strain was present as a very small percentage of the culture. The method was successfully used to purify a serovariant but could also be used to select a rare C. trachomatis strain which had undergone a mutation in the MOMP neutralizing epitope. Our ability to purify one serovar from a mixture of two C.
trachomatis serotypes demonstrates the effectiveness of the neutralization procedure described by Su et al. (6) . 
